The focus of this study was underpinned by the common reactivation of ZEB1, ZEB2 and TWIST1 in aggressive and undifferentiated human breast cancers, especially in the newly identified claudin-low intrinsic subtype [13]. Here, ZEB1 is linked to breast cancer.